Research progress of lncRNAs in diabetic retinopathy

Eur J Ophthalmol. 2021 Jul;31(4):1606-1617. doi: 10.1177/1120672120970401. Epub 2020 Nov 11.

Abstract

Diabetic retinopathy (DR), which is known as a severe complication of type 2 diabetes mellitus, can cause varying degrees of damage to visual acuity. The pathogenesis of DR is multifactorial and not fully understood. Many previous research studies have revealed that an aberrant level of some long non-coding RNAs (lncRNAs) may accelerate the development of DR. These lncRNAs are regulatory factors and research related to them is always underway. In this review, we will update several types of lncRNAs based on the previous studies which are related to the development of DR and discuss its potential mechanisms of action and connections. Generally, the review will help us know more about lncRNAs and provide directions for future research related to DR.

Keywords: diabetic retinopathy; lncRNAs; progression.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / genetics
  • Diabetic Retinopathy* / genetics
  • Humans
  • RNA, Long Noncoding* / genetics
  • Visual Acuity

Substances

  • RNA, Long Noncoding